Co-Authors
This is a "connection" page, showing publications co-authored by John S. Cooperwood and Musiliyu Musa.
Connection Strength
2.069
-
Musa MA, Joseph MY, Latinwo LM, Badisa V, Cooperwood JS. In vitro evaluation of 3-arylcoumarin derivatives in A549 cell line. Anticancer Res. 2015 Feb; 35(2):653-9.
Score: 0.533
-
Musa MA, Khan MO, Aspedon A, Cooperwood JS. Synthesis and Antimicrobial Activity of N,N'-Bis(2-hydroxylbenzyl)-1,2-ethanediamine Derivatives. Lett Drug Des Discov. 2010 Mar; 7(3):165-170.
Score: 0.379
-
Musa MA, Khan MO, Cooperwood JS. Synthesis and antiproliferative activity of coumarin-estrogen conjugates against breast cancer cell lines. Lett Drug Des Discov. 2009 Mar; 6(2):133-138.
Score: 0.353
-
Musa MA, Khan MO, Cooperwood JS. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs). Curr Med Chem. 2007; 14(11):1249-61.
Score: 0.304
-
Wan Z, Musa MA, Joseph P, Cooperwood JS. Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents. Mini Rev Med Chem. 2013 Jul; 13(9):1381-8.
Score: 0.119
-
Musa MA, Badisa VL, Latinwo LM, Cooperwood J, Sinclair A, Abdullah A. Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines. Anticancer Res. 2011 Jun; 31(6):2017-22.
Score: 0.103
-
Musa MA, Cooperwood JS, Khan MO, Rahman T. In-vitro antiproliferative activity of benzopyranone derivatives in comparison with standard chemotherapeutic drugs. Arch Pharm (Weinheim). 2011 Feb; 344(2):102-10.
Score: 0.100
-
Cooperwood JS, Edwards J, Musa M, Simmons D, Mian AD, Park KK, Wan Z. Synthesis and Evaluation of Estradiol Derivatives as Anti-Breast Cancer Agents. Lett Drug Des Discov. 2010 Jul 01; 7(6):389-394.
Score: 0.097
-
Musa MA, Cooperwood JS, Khan MO. A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem. 2008; 15(26):2664-79.
Score: 0.081